Umifenovir
- Generic Name
- Umifenovir
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C22H25BrN2O3S
- CAS Number
- 131707-25-0
- Unique Ingredient Identifier
- 93M09WW4RU
- Background
Umifenovir is an indole-based, hydrophobic, dual-acting direct antiviral/host-targeting agent used for the treatment and prophylaxis of influenza and other respiratory infections. It has been in use in Russia for approximately 25 years and in China since 2006. Its invention is credited to a collaboration between Russian scientists from several research insti...
- Indication
Umifenovir is currently licensed in China and Russia for the prophylaxis and treatment of influenza and other respiratory viral infections. It has demonstrated activity against a number of viruses and has been investigated in the treatment of Flavivirus, Zika virus, foot-and-mouth disease, Lassa virus, Ebola virus, and herpes simplex. In addition, it has sho...
- Associated Conditions
- -
- Associated Therapies
- -
Umifenovir in Hospitalized COVID-19 Patients
- First Posted Date
- 2020-04-17
- Last Posted Date
- 2020-04-20
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Target Recruit Count
- 40
- Registration Number
- NCT04350684
- Locations
- 🇮🇷
Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences and Health Services, Tehran, Iran, Islamic Republic of
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.